In the US, Monodox (doxycycline systemic) is a member of the following drug classes: miscellaneous antimalarials, tetracyclines and is used to treat Acne, Actinomycosis, Amebiasis, Anthrax, Anthrax Prophylaxis, Bacterial Infection, Bartonellosis, Bronchitis, Brucellosis, Bullous Pemphigoid, Cervicitis, Chancroid, Chlamydia Infection, Cholera, Cutaneous Bacillus anthracis, Ehrlichiosis, Enterocolitis, Epididymitis - Sexually Transmitted, Gastroenteritis, Gonococcal Infection - Uncomplicated, Granuloma Inguinale, Lyme Disease, Lyme Disease - Arthritis, Lyme Disease - Carditis, Lyme Disease - Erythema Chronicum Migrans, Lyme Disease - Neurologic, Lymphogranuloma Venereum, Malaria, Malaria Prevention, Melioidosis, Mycoplasma Pneumonia, Nongonococcal Urethritis, Ocular Rosacea, Pelvic Inflammatory Disease, Pemphigoid, Pemphigus, Periodontitis, Plague, Pleural Effusion, Pneumonia, Proctitis, Prostatitis, Psittacosis, Rabbit Fever, Rickettsial Infection, Rosacea, Skin or Soft Tissue Infection, STD Prophylaxis, Syphilis - Early, Syphilis - Latent, Tertiary Syphilis, Trachoma, Upper Respiratory Tract Infection and Urinary Tract Infection.
Ingredient matches for Monodox
Doxycycline monohydrate (a derivative of Doxycycline) is reported as an ingredient of Monodox in the following countries:
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.